{"id":555550,"date":"2026-06-02T21:58:31","date_gmt":"2026-06-02T19:58:31","guid":{"rendered":"https:\/\/medizinonline.com\/?p=555550"},"modified":"2026-06-02T21:58:42","modified_gmt":"2026-06-02T19:58:42","slug":"inibidores-sglt2-com-vantagens-em-relacao-aos-inibidores-dpp4","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/inibidores-sglt2-com-vantagens-em-relacao-aos-inibidores-dpp4\/","title":{"rendered":"Inibidores SGLT2 com vantagens em rela\u00e7\u00e3o aos inibidores DPP4"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Os inibidores SGLT2 est\u00e3o associados a um risco significativamente menor de dem\u00eancia, incluindo a doen\u00e7a de Alzheimer e a dem\u00eancia vascular, em compara\u00e7\u00e3o com os inibidores DPP4. O benef\u00edcio observado foi consistente em diferentes subgrupos e foi particularmente evidente para a dapagliflozina e empagliflozina, enquanto n\u00e3o houve um efeito claro para outros agentes. <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Finibidores-sglt2-com-vantagens-em-relacao-aos-inibidores-dpp4%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Os inibidores SGLT2 est\u00e3o associados a um risco significativamente menor de dem\u00eancia, incluindo a doen\u00e7a de Alzheimer e a dem\u00eancia vascular, em compara\u00e7\u00e3o com os inibidores DPP4. O benef\u00edcio observado&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Finibidores-sglt2-com-vantagens-em-relacao-aos-inibidores-dpp4%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":555551,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Risco de dem\u00eancia com diabetes tipo 2  ","footnotes":""},"category":[11397,11521,11453,11524,11360,11374,11481,11551],"tags":[23326,12159,30960,15084,63455,33459,41554],"powerkit_post_featured":[],"class_list":["post-555550","post","type-post","status-publish","format-standard","has-post-thumbnail","category-endocrinologia-e-diabetologia-2","category-estudos","category-farmacologia-e-toxicologia","category-formacao-continua","category-geriatria-pt-pt","category-neurologia-pt-pt","category-psiquiatria-e-psicoterapia","category-rx-pt","tag-dapagliflozin-pt-pt","tag-demencia-pt-pt","tag-demencia-por-alzheimer","tag-demencia-vascular","tag-inibidor-dpp4","tag-inibidores-sglt2-pt-pt","tag-risco-de-demencia","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-11 01:22:48","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":555563,"slug":"inhibidores-sglt2-con-ventajas-frente-a-los-inhibidores-dpp4","post_title":"Inhibidores SGLT2 con ventajas frente a los inhibidores DPP4","href":"https:\/\/medizinonline.com\/es\/inhibidores-sglt2-con-ventajas-frente-a-los-inhibidores-dpp4\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/555550","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=555550"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/555550\/revisions"}],"predecessor-version":[{"id":555552,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/555550\/revisions\/555552"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/555551"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=555550"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=555550"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=555550"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=555550"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}